LANSOPRAZOLE
- Product NDC
- 70934-369
- 11-digit product format
- 709340369
- Labeler code
- 70934
- Product ID
- 70934-369_b078bf43-bfd1-f45a-e053-2995a90ac57f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LANSOPRAZOLE
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA201921
- Marketing category
- ANDA
- Marketing start
- 2019-05-21
- Marketing end
- 0000-00-00
- Substance
- LANSOPRAZOLE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Inhibition Gastric Acid Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-369-30 | 70934036930 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70934-369-30) | 2019-05-21 | 0000-00-00 | No | No | Current |